QURE Uniqure Nv

uniQure NV is engaged in the field of gene therapy platform across three therapeutic focus areas: Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.

$34.90  +0.02 (0.06%)
As of 04/14/2021 15:59:51 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  The Netherlands
Country of incorporation:  The Netherlands
IPO date:  02/05/2014
Outstanding shares:  44,993,987
Average volume:  519,562
Market cap:   $1,569,390,267
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    N90064101
ISIN:        NL0010696654
Sedol:      BJFSR88
Valuation   (See tab for details)
PE ratio:   -12.55
PB ratio:   6.40
PS ratio:   41.83
Return on equity:   -51.26%
Net income %:   -333.27%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy